GlassScriptPhysician profile
Hannah M Hall
NPI 1548423957
$1,103.80
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $142 · 2024: $209 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $340.27 | 2019 | |
| Merck Sharp & Dohme LLC | $112.31 | 2019-2020 | |
| Biogen, INC. | $110.84 | 2025 | Zurzuvae |
| Abbvie INC. | $104.29 | 2019-2025 | |
| Astellas Pharma US INC | $97.05 | 2019-2025 | Veozah |
| Pfizer INC. | $70.70 | 2024 | |
| Amgen INC. | $64.20 | 2020-2024 | Evenity, Prolia |
| Smith+Nephew, INC. | $52.56 | 2024-2025 | Pico 7, Pico 14 |
| Organon LLC | $50.63 | 2024-2025 | Jada System |
| Amag Pharmaceuticals, INC. | $27.85 | 2019 | |
| Hologic Sales and Service, LLC | $23.63 | 2025 | Aptima |
| Duchesnay USA Incorporated | $19.21 | 2019 | |
| Exeltis, USA INC. | $16.10 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.